Home / Pipeline / Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella + Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine + Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella Products Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella + Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine + Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella
Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella + Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine + Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella Approved Completed ⚡ Active Interest: 43/100
Measles, Mumps, Rubella, Hepatitis A
Sep 1, 2006 → Apr 1, 2010
About Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella + Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine + Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella + Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine + Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella is a approved stage product being developed by Sanofi for Measles. The current trial status is completed. This product is registered under clinical trial identifier NCT00313950. Target conditions include Measles, Mumps, Rubella.
What happened to similar drugs? 3 of 17 similar drugs in Measles were approved
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT00313950 Approved Completed Sep 1, 2006 Apr 1, 2010 Measles
Product Company Stage Hype Score Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd + Yellow fever Vaccine (WHO prequalified) Zydus Lifesciences Phase 3 MMRV (AMP) + MMRV (2006 process) Merck Phase 3 M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX® Merck Phase 3 Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (ProQuad™) + M-M-R™ II and Varivax™ Merck Phase 3 Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: M-M-R II + Comparator: PUVV Merck Phase 2 Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Varivax + Comparator: M-M-R II Merck Phase 3 ProQuad® manufactured with recombinant Human Albumin (rHA) Merck Phase 3 Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live + Comparator: VARIVAX(TM) Varicella Virus Vaccine Live (Oka-Merck) Merck Phase 3 measles, mumps, and rubella virus vaccine live + Comparator: Measles, Mumps, and Rubella Virus Vaccine Live Merck Phase 2 Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Tripedia + Comparator: Comvax + Comparator: Varivax + Comparator: M-M-R II Merck Phase 3 V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks Merck Phase 3 V205C, measles, mumps, and rubella virus vaccine live + Comparator: Measles, Mumps, and Rubella Virus Vaccine Live Merck Phase 2 Comparator: ProQuad™ (V221) + Comparator: PREVNAR™ (pneumococcal 7-valent conjugate vaccine) Merck Phase 3 Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Placebo + Comparator: Varivax + Comparator: M-M-R II Merck Phase 3 ProQuad® Merck Phase 3 MMR vaccine Merck Pre-clinical ProQuad® Merck Phase 3 ProQuad (Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live) + Comparator: M-M-R II + Comparator: Varivax + Comparator: Placebo Merck Phase 3 Measles vaccine Novo Nordisk Approved Measles vaccine Novo Nordisk Approved